FDA Panel Votes Against Authorizing Sabizabulin For Treatment Of High-Risk Patients Hospitalized With COVID-19

Reuters (11/9, Satija, Mahobe) reports “a panel of outside advisers to the” FDA “on Wednesday voted against authorizing Veru Inc’s drug for treating high-risk patients hospitalized with COVID-19, citing multiple concerns over efficacy and safety data bein...